Funded Tech Companies
Mersana Therapeutics
Mersana Therapeutics is a biopharmaceutical company, located in Cambridge. Investment was provided by Takeda Ventures, Wellington Management Company and New Enterprise Associates.
Company Overview
Company Name
Mersana Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is focused on developing novel oncology agents based on Fleximer, a stealth material that enhances the pharmacokinetics and safety of drugs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/27/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anna Protopapas
Chief Medical Officer
Dirk Huebner
Chief Scientific Officer
Timothy Lowinger
VP - Bus. Development
Eva Jack
VP - Finance
Brian DeSchuytner
VP - Manufacturing
Michael Kaufman
Company Investors
- Takeda Ventures
- Wellington Management Company
- New Enterprise Associates (David Mott)
- Rock Springs Capital
- Arrowpoint Partners
- Cormorant Asset Management
- Pfizer Venture Investments
- F-Prime Capital (Thomas Beck)
- Private Investors (Elliott Sigal)
- Harris & Harris Group
- Rho Ventures (Martin Vogelbaum)
- ProQuest Investments (Joyce Tsang)
- F-Prime Capital (Jason Rhodes)
- PureTech Ventures
- Harris & Harris Group (Charles Harris)
- ProQuest Investments (Jay Moorin)
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs